Unity Biotechnology Q1 EPS $(0.28) Up From $(0.29) YoY
Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.28) per share. This is a 3.45 percent increase over losses of $(0.29) per share from the same period last year.
Unity Biotechnology (NASDAQ:UBX) reported quarterly losses of $(0.28) per share. This is a 3.45 percent increase over losses of $(0.29) per share from the same period last year.